Related Experiment Video
Updated: Jan 1, 2026

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
Published on: August 8, 2025
Efficacy and Safety of Transcarotid Transcatheter Aortic Valve Replacement: A Systematic Review
Tamunoinemi Bob-Manuel1, Hussein Almusawi2, Tameem Rezan1
1John Ochsner Heart and Vascular Center, New Orleans, LA, USA.
Insights
Transcatheter aortic valve replacement (TAVR) via carotid artery (CA) access offers excellent device success and low complication rates for patients unsuitable for traditional TAVR methods. This approach demonstrates favorable outcomes compared to other TAVR access routes.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Surgical Innovation
Background:
- Transcatheter aortic valve replacement (TAVR) is a critical treatment for aortic stenosis.
- Traditional TAVR access routes may be unsuitable for patients with severe peripheral vascular disease or high surgical risk.
- Carotid artery (CA) access is an emerging alternative TAVR approach.
Purpose of the Study:
- To systematically review and analyze the most up-to-date outcomes of TAVR performed via carotid artery access.
- To compare the safety and efficacy of carotid access TAVR with other vascular access sites.
Main Methods:
- A systematic review was conducted following PRISMA guidelines.
- Comprehensive literature searches were performed in PubMed, SCOPUS, and Embase databases.
- Statistical analysis was performed using SPSS version 24.
Main Results:
- Fifteen non-randomized studies involving 2524 TAVR patients were analyzed across five access sites: transcarotid (TC), transfemoral (TF), transapical (TAP), transaortic (TAO), and transaxillary (TAX).
- Transcarotid TAVR demonstrated high device success (95.6%), with 30-day and 1-year mortality rates of 4.2% and 10.5%, respectively.
- Compared to transaortic access, transcarotid access showed significantly lower 30-day mortality (2.6% vs. 12.1%). Stroke/TIA rates were 5% at 30 days, with no hemorrhagic strokes. Pacemaker implantation was required in 15.3% of TC cases.
Conclusions:
- Carotid artery access for TAVR is a viable option with impressive device success and low complication rates, including stroke and pacemaker implantation.
- Outcomes for transcarotid TAVR are comparable to transapical and transaxillary approaches.
- Transcarotid TAVR offers a significantly safer alternative regarding 30-day mortality compared to transaortic TAVR.
Background:
In patients who are not suitable for traditional access routes for transcatheter aortic valve replacement (TAVR) due to severe peripheral vascular disease (PVD) or prohibitive surgical risk, carotid artery (CA) access is an emerging route for TAVR. This study represents the most up to date on outcomes of carotid access TAVR.
Methods:
A systematic review was conducted as per the Preferred Reporting Instructions for Systematic Reviews and Meta-analysis (PRISMA). We performed a thorough electronic search through Pubmed, SCOPUS and Embase databases. Statistical analyses were performed using SPSS version 24 (IBM Corporation, Armonk, New York, USA).
Results:
A total of 15 non-randomized studies were included in this systematic review comprising of patients that received TAVR via 4 vascular access sites, transcarotid (TC) (N = 1035), transfemoral (TF) (N = 1116), transapical (TAP) (N = 307), transaortic (TAO) (N = 176) and transaxillary (TAX) (N = 90). In the Transcarotid cases, device success was achieved in 95.6% of patients (n = 748). The 30-day and 1-yr mortality was 4.2% and 10.5% respectively. 15.3% of patients required new pacemaker implantation. In-hospital stroke or TIA occurred in 4% of cases. 30-day stroke or TIA occurred in 5% of cases. There were no hemorrhagic strokes. 30-day Mortality was significantly higher in the Transaortic group (12.1%) compared to the Transcarotid group (2.6%) [RR = 2.93 95% CI = 1.15-7.58; p = 0.027]. There were no differences in outcomes between the Transcarotid group and the Transapical or Transaxillary groups.
Conclusion:
The most contemporary data on Carotid access TAVR shows impressive device success, low rates of stroke and pacemaker implantation and an acceptable 30-day and 1-year mortality. 30-day mortality was significantly lower in TC compared to TAO patients.
More Related Videos
06:59Improved Registration of 3D CT Angiography with X-ray Fluoroscopy for Image Fusion During Transcatheter Aortic Valve Implantation
Published on: June 3, 2018
08:50Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
Published on: March 26, 2018
Related Concept Videos
Aortic Regurgitation III: Medical Management
Aortic Regurgitation II: Clinical Features and Diagnostic Tests